International Track 200

Focus Pharmaceuticals was formed in 2003, when Mark Cresswell, 47, Roland Brown, 43, and Ray Maginley, 52, led a buyout of ADL Healthcare’s generics business. The Staffordshire company licenses, markets, and distributes niche generic medicines throughout Britain, continental Europe and farther afield. It also develops pharmaceuticals to compete with branded drugs coming off patent. In 2013, it launched seven new products. Exports totalled £2m in 2013.

This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.

Company details
CompanyFocus Pharmaceuticals
ActivityPharmaceutical products licensing
2-yr av intl sales growth pa40.78%
International sales £000s1,990
Total sales £000s32,079

If applicable:

* Supplied by company † Annualised figure